Literature DB >> 14888822

Studies on the psittacosis-lymphogranuloma group. 1. The pattern of multiplication of meningopneumonitis virus in the allantois of the chick embryo.

M M SIGEL, A J GIRARDI, E G ALLEN.   

Abstract

Because of the peculiar properties of the psittacosis-lymphogranuloma group of viruses, the pattern of multiplication in the allantois of the chick embryo of one of their number, meningopneumonitis virus, was studied. This was done by determination of the changes in its infectivity for mice and chick embryos. Titration of infectivity in embryos proved to be a more sensitive procedure than titration in mice; the latter procedure however, had the advantage of greater simplicity and gave more clear-cut results. The mouse titration method was used in most of the experiments. Following inoculation of virus into the allantois, there was a slow decrease in infectivity in the allantoic fluids followed by an increase due to appearance of new virus between 24 and 48 hours. The slope of declining infectivity in the allantoic fluids in ovo was similar if not identical with the slope of decreasing infectivity in allantoic fluids in vitro caused by thermal degradation of virus. Multiplication of the virus in allantoic membranes was characterized by the following pattern: (a) Increase in infectivity in the first few hours (exact duration of increase depended on concentration of virus in inoculum) due to adsorption of virus. (b) Decrease in infectivity up to about 20 to 24 hours. (c) Increase in infectivity due to appearance of the new generation of virus. The growth curve of meningopneumonitis is analyzed and the pattern of growth is discussed in the light of the present concepts of viral multiplication.

Entities:  

Keywords:  MIYAGAWANELLA; VIRUSES

Mesh:

Year:  1951        PMID: 14888822      PMCID: PMC2180329          DOI: 10.1084/jem.94.5.401

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  3 in total

1.  Purification and properties of the agent of feline pneumonitis.

Authors:  J W MOULDER; E WEISS
Journal:  J Infect Dis       Date:  1951 Jan-Feb       Impact factor: 5.226

2.  STUDIES ON LYMPHOGRANULOMA VENEREUM : I. DEVELOPMENT OF THE AGENT IN THE YOLK SAC OF THE CHICKEN EMBRYO.

Authors:  G Rake; H P Jones
Journal:  J Exp Med       Date:  1942-03-01       Impact factor: 14.307

3.  MORPHOLOGICAL AND OTHER CHARACTERISTICS OF THE AGENT OF FELINE PNEUMONITIS GROWN IN THE ALLANTOIC CAVITY OF THE CHICK EMBRYO.

Authors:  D Hamre; H Rake; G Rake
Journal:  J Exp Med       Date:  1947-06-30       Impact factor: 14.307

  3 in total
  7 in total

1.  Structure and development of viruses of the psittacosis-lymphogranuloma group observed in the electron microscope.

Authors:  M TAJIMA; Y NOMURA; Y KUBOTA
Journal:  J Bacteriol       Date:  1957-11       Impact factor: 3.490

2.  The mode of virus multiplication and the susceptibility of these agents to the antibiotics.

Authors:  S P BEDSON
Journal:  J Clin Pathol       Date:  1956-05       Impact factor: 3.411

3.  A study of the mode of multiplication of psittacosis virus.

Authors:  S P BEDSON; J V GOSTLING
Journal:  Br J Exp Pathol       Date:  1954-06

4.  Studies on the psittacosis-lymphogranuloma group. II. A non-infectious phase in virus development following adsorption to host tissue.

Authors:  A J GIRARDI; E G ALLEN; M M SIGEL
Journal:  J Exp Med       Date:  1952-09       Impact factor: 14.307

5.  Studies on the psittacosislymphogranuloma group. III. The effect of aureomycin on the propagation of virus in the chick embryo.

Authors:  E G ALLEN; A J GIRARDI; M M SIGEL; M KLEIN
Journal:  J Exp Med       Date:  1953-06       Impact factor: 14.307

6.  Studies on the factors essential to the initiation and maintenance of multiplication of psittacosis virus (6BC strain) in deficient cells in tissue culture.

Authors:  J D HARE; H R MORGAN
Journal:  J Exp Med       Date:  1954-05-01       Impact factor: 14.307

7.  Intracellular forms of meningopneumonitis virus.

Authors:  W H GAYLORD
Journal:  J Exp Med       Date:  1954-12-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.